BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24378824)

  • 1. Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder.
    Ebbing J; Mathia S; Seibert FS; Pagonas N; Bauer F; Erber B; Günzel K; Kilic E; Kempkensteffen C; Miller K; Bachmann A; Rosenberger C; Zidek W; Westhoff TH
    World J Urol; 2014 Dec; 32(6):1485-92. PubMed ID: 24378824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Calprotectin Differentiates Between Prerenal and Intrinsic Acute Renal Allograft Failure.
    Seibert FS; Rosenberger C; Mathia S; Arndt R; Arns W; Andrea H; Pagonas N; Bauer F; Zidek W; Westhoff TH
    Transplantation; 2017 Feb; 101(2):387-394. PubMed ID: 26901081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of S100A8, S100A9 and calprotectin levels in bladder cancer.
    Yasar O; Akcay T; Obek C; Turegun FA
    Scand J Clin Lab Invest; 2017 Oct; 77(6):437-441. PubMed ID: 28609200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury.
    Seibert FS; Pagonas N; Arndt R; Heller F; Dragun D; Persson P; Schmidt-Ott K; Zidek W; Westhoff TH
    Acta Physiol (Oxf); 2013 Apr; 207(4):700-8. PubMed ID: 23336369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer.
    Bausch K; Roth E; Heinz S; Horst D; Mathia S; Vlajnic T; Bubendorf L; Westhoff T; Wetterauer C; Seifert HH; Ebbing J
    PLoS One; 2019; 14(3):e0213549. PubMed ID: 30870488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury.
    Heller F; Frischmann S; Grünbaum M; Zidek W; Westhoff TH
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2347-55. PubMed ID: 21885792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary calprotectin as a diagnostic tool for detecting significant bacteriuria.
    Waldecker-Gall S; Waldecker CB; Babel N; Baraliakos X; Seibert F; Westhoff TH
    Sci Rep; 2024 May; 14(1):12230. PubMed ID: 38806578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of calprotectin, CD147, APOA4 and DJ-1 in non-invasive detection of urinary bladder carcinoma.
    Soukup V; Capoun O; Pesl M; Vavrova L; Sobotka R; Levova K; Hanus T; Zima T; Kalousova M
    Neoplasma; 2019 Nov; 66(6):1019-1023. PubMed ID: 31607136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response.
    Sahin Y; Yucetas U; Ates HA; Erkan E; Yucetas E; Temiz MZ; Toktas MG; Kadihasanoglu M; Topkaya BC
    Investig Clin Urol; 2019 Sep; 60(5):343-350. PubMed ID: 31501796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
    Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
    Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
    Svatek RS; Karam J; Karakiewicz PI; Gallina A; Casella R; Roehrborn CG; Shariat SF
    J Urol; 2008 Feb; 179(2):478-84; discussion 484. PubMed ID: 18076936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma.
    Soukup V; Kalousová M; Capoun O; Sobotka R; Breyl Z; Pešl M; Zima T; Hanuš T
    Urol Int; 2015; 95(1):56-64. PubMed ID: 25662337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of Urinary Calprotectin after Renal Ischaemia.
    Ebbing J; Seibert FS; Pagonas N; Bauer F; Miller K; Kempkensteffen C; Günzel K; Bachmann A; Seifert HH; Rentsch CA; Ardelt P; Wetterauer C; Amico P; Babel N; Westhoff TH
    PLoS One; 2016; 11(1):e0146395. PubMed ID: 26745147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the nuclear matrix protein 22 Bladder Chek test™ in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer.
    Balci M; Tuncel A; Guzel O; Aslan Y; Sezgin T; Bilgin O; Senel C; Atan A
    Int Urol Nephrol; 2015 Mar; 47(3):473-7. PubMed ID: 25649031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis.
    Iwaki H; Kageyama S; Isono T; Wakabayashi Y; Okada Y; Yoshimura K; Terai A; Arai Y; Iwamura H; Kawakita M; Yoshiki T
    Cancer Sci; 2004 Dec; 95(12):955-61. PubMed ID: 15596044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary calreticulin in the diagnosis of bladder urothelial carcinoma.
    Kageyama S; Isono T; Matsuda S; Ushio Y; Satomura S; Terai A; Arai Y; Kawakita M; Okada Y; Yoshiki T
    Int J Urol; 2009 May; 16(5):481-6. PubMed ID: 19389084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
    de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
    Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury.
    Westhoff JH; Fichtner A; Waldherr S; Pagonas N; Seibert FS; Babel N; Tönshoff B; Bauer F; Westhoff TH
    Pediatr Nephrol; 2016 Dec; 31(12):2353-2363. PubMed ID: 27286687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
    Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.